Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced data from a post hoc analysis of the GALE extension study ...

"Substantial risk reductions." Researchers make AI-powered discoveries that could transform farming as we know it: 'Could ...

Detailed price information for Apellis Pharmaceuticals Inc (APLS-Q) from The Globe and Mail including charting and trades.

Generated $459 million in 3Q 2025 revenues, including $178 million in U.S. net product salesReceived 152 new patient start forms for EMPAVELI® (pegcetacoplan) in the first two months since launch in ...

Angelica Facoetti explains five facts accelerator physicists need to know about radiobiology to work at the cutting edge of ...

We are proud to continuously support the study of interventional glaucoma treatment, especially in highlighting critical groups of patients that may benefit from active surgical interventions. These ...

Judges rule some Florida gun laws are unconstitutional. Here's what to know ...

In lead collisions at the LHC, some of the strongest electromagnetic fields in the universe bombard the inside of the beam ...

Roughly two months after naming a new CEO, Target said it plans to cut an estimated 1,800 corporate jobs in an effort to offset the retailer's stagnant sales numbers, according to multiple reports ...

I recently wrote about how fund investors’ stake in US equity has drifted higher over the past decade. That increase owes mostly to US stocks’ standout returns over that period, rather than investors’ ...

Target Corp. is eliminating about 8% of corporate roles in its first major restructuring in years, according to a memo viewed by Bloomberg News, as the retailer seeks to reduce complexity and regain ...